Skip to main content
. 2022 Mar 29;14(7):1747. doi: 10.3390/cancers14071747

Table 2.

Clinical response of patients during treatment.

Response RECIST 1.1 Modified RECIST
LENV Group ATE/BEV Group p-Value LENV Group ATE/BEV Group p-Value
Complete response 2 (1.4) 3 (3.5) 0.745 2 (1.4) 3 (3.5) 0.742
Partial response 44 (30.1) 25 (29.1) 47 (32.2) 27 (31.4)
Stable disease 66 (45.2) 37 (43.0) 63 (43.2) 35 (40.7)
Progressive disease 34 (23.3) 21 (24.4) 34 (23.3) 21 (24.4)
Objective response rate 31.5 32.6 0.868 33.6 34.9 0.485
Disease control rate 76.7 75.6 0.760 76.8 75.6 0.682

Data are presented as n (%) or %, as appropriate. RECIST, Response Evaluation Criteria in Solid Tumors.